Department of Medicine, Division of Cardiovascular Medicine, Stony Brook University Hospital, Stony Brook, New York.
Duke Clinical Research Institute, Durham, North Carolina.
JACC Cardiovasc Interv. 2015 Dec 28;8(15):1954-1962. doi: 10.1016/j.jcin.2015.08.030.
The aim of this study was to compare outcomes of ST-segment elevation myocardial infarction (STEMI) patients with a history of coronary artery bypass graft surgery (CABG), previous percutaneous coronary intervention (PCI), or no previous revascularization undergoing primary PCI.
Limited data exist regarding door-to-balloon times and clinical outcomes of STEMI patients with a history of CABG or PCI undergoing primary PCI.
We examined 15,628 STEMI patients who underwent primary PCI at 297 sites in the United States. We used multivariable logistic regression analyses to compare door-to-balloon time delays >90 min and in-hospital major adverse cardiovascular or cerebrovascular events (MACCE).
Patients with previous CABG were significantly older and more likely to have multiple comorbidities (p < 0.0001). Previous CABG was associated with a lower likelihood of a door-to-balloon time ≤90 min compared with patients with no previous revascularization. However, no significant differences in door-to-balloon times were noted between patients with previous PCI and those without previous revascularization. The unadjusted MACCE risk was significantly higher in patients with a history of CABG compared with patients without previous revascularization (odds ratio: 1.68, 95% confidence interval: 1.23 to 2.31). However, after multivariable risk adjustment, there were no significant differences in MACCE risk between the 2 groups. No significant differences in in-hospital outcomes were seen in patients with a previous PCI and those without previous revascularization.
In a large cohort of STEMI patients undergoing primary PCI, patients with previous CABG were more likely to have reperfusion delays, yet risk-adjusted, in-hospital outcomes were similar to those without previous revascularization. No significant differences in reperfusion timeliness and in-hospital outcomes were seen in patients with a history of PCI compared with patients without previous revascularization.
本研究旨在比较行直接经皮冠状动脉介入治疗(PCI)的既往冠状动脉旁路移植术(CABG)、既往 PCI 或无再血管化史的 ST 段抬高型心肌梗死(STEMI)患者的结局。
关于行直接 PCI 的既往 CABG 或 PCI 的 STEMI 患者的门球时间和临床结局,相关数据有限。
我们检查了在美国 297 个地点接受直接 PCI 的 15628 例 STEMI 患者。我们使用多变量逻辑回归分析比较了门球时间延迟>90 分钟和住院期间主要不良心血管或脑血管事件(MACCE)。
既往 CABG 患者年龄明显较大,且更可能合并多种合并症(p<0.0001)。与无再血管化史的患者相比,既往 CABG 与门球时间≤90 分钟的可能性较低相关。然而,既往 PCI 与无再血管化史的患者之间的门球时间无显著差异。与无再血管化史的患者相比,既往 CABG 史患者的未调整 MACCE 风险显著更高(优势比:1.68,95%置信区间:1.23 至 2.31)。然而,在多变量风险调整后,两组间 MACCE 风险无显著差异。既往 PCI 与无再血管化史的患者之间的住院结局无显著差异。
在接受直接 PCI 的大量 STEMI 患者中,既往 CABG 患者更有可能发生再灌注延迟,但经风险调整后,住院结局与无再血管化史的患者相似。与无再血管化史的患者相比,既往 PCI 史患者的再灌注及时性和住院结局无显著差异。